PR Newswire  | 

Thinking about buying stock in CohBar, Mogo, BioCryst Pharmaceuticals, Hoth Therapeutics, or Maravai Lifesciences?

PR Newswire

play Anhören
share Teilen
feedback Feedback
copy Kopieren
newsletter
ARIVA Newsletter
BioCryst Pharmaceuticals Inc 8,91 $ BioCryst Pharmaceuticals Inc Chart +2,30%
COHBAR INC -   COHBAR INC Chart 0,00%
Hoth Therapeutics Inc 0,9021 $ Hoth Therapeutics Inc Chart +1,05%
Maravai Lifesciences Holdings Inc 2,07 $ Maravai Lifesciences Holdings Inc Chart +2,22%
Mogo Finance Technology -   Mogo Finance Technology Chart 0,00%

NEW YORK, Aug. 11, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CWBR, MOGO, BCRX, HOTH, and MRVI.

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-cohbar-mogo-biocryst-pharmaceuticals-hoth-therapeutics-or-maravai-lifesciences-301353218.html

SOURCE InvestorsObserver


Für dich aus unserer Redaktion zusammengestellt

Community-Beiträge zu Maravai Lifesciences Holdings Inc

aus Forum-Thread: entdeckt: neue microsoft
Avatar des Verfassers
05.09.2022 - 06:50 Uhr
Chalifmann3
hi
Declining Stock and Solid Fundamentals: Is The Market Wrong About Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)?Simply Wall StMon, August 29, 2022 at 7:47 PMIn this article:MRVI-0.29%With its stock down 35% over the past three months, it is easy to disregard Maravai LifeSciences Holdings (NASDAQ:MRVI). However, a closer ...
Avatar des Verfassers
24.07.2022 - 07:53 Uhr
Chalifmann3
darum gehts,bereits hochprofitabel
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for ...
Jetzt anmelden und diskutieren Registrieren Login

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Weitere Artikel des Autors

Themen im Trend